Non-invasive device using muscular counter pulsation (MCP) technology for the treatment of acute and chronic heart failure (CHF) in a clinical, ambulatory, or at-home setting
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Cardiola plus 4709 other start-ups.
